Driehaus Capital Management’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $490K | Hold |
32,765
| – | – | ﹤0.01% | 388 |
|
|
2025
Q1 | $384K | Hold |
32,765
| – | – | ﹤0.01% | 377 |
|
|
2024
Q4 | $749K | Sell |
32,765
-69,422
| -68% | -$1.59M | 0.01% | 340 |
|
|
2024
Q3 | $4.29M | Hold |
102,187
| – | – | 0.04% | 286 |
|
|
2024
Q2 | $3.72M | Buy |
102,187
+56,533
| +124% | +$2.06M | 0.04% | 272 |
|
|
2024
Q1 | $2.32M | Buy |
+45,654
| New | +$2.32M | 0.02% | 301 |
|
|
2019
Q4 | – | Sell |
-2,500
| Closed | -$143K | – | 547 |
|
|
2019
Q3 | $143K | Buy |
+2,500
| New | +$143K | ﹤0.01% | 477 |
|
|
2015
Q3 | – | Sell |
-8,215
| Closed | -$1.14M | – | 556 |
|
|
2015
Q2 | $1.14M | Sell |
8,215
-2,057
| -20% | -$285K | 0.04% | 400 |
|
|
2015
Q1 | $1.76M | Sell |
10,272
-2,195
| -18% | -$377K | 0.06% | 346 |
|
|
2014
Q4 | $1.87M | Sell |
12,467
-4,512
| -27% | -$677K | 0.08% | 322 |
|
|
2014
Q3 | $2.26M | Buy |
16,979
+372
| +2% | +$49.6K | 0.09% | 292 |
|
|
2014
Q2 | $3.11M | Sell |
16,607
-8,923
| -35% | -$1.67M | 0.1% | 271 |
|
|
2014
Q1 | $6.5M | Buy |
+25,530
| New | +$6.5M | 0.2% | 136 |
|